Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System

This is a pilot trial of centrifugal machine preservation of donor livers for transplantation using a novel preservation solution.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Liver Transplantation Organ Preservation

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Primary/ Solitary Liver Transplant
Lab MELD<35
Donor age <65

Exclusion criteria

Donor Liver > 30% Macrosteatosis
DCD donor liver
Multi-organ Recipient
Recipient in ICU
Retransplant

Treatment and study plan

Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System

Device

Utilization of Vasosol with Medtronic System for Machine Preservation of the Liver for Liver Transplantation

Other names: Vasosol Solution, Medtronic Portable Bypass System

Sponsors and collaborators

Lead sponsor

Polyak, Maximilian

Indiv

Collaborators

Health Resources and Services Administration (HRSA)

Registry information

Official study title

Phase 1 Study of Liver Machine Preservation With Vasosol Solution

Important dates

Study start: 2004
Primary completion: 2008
Study completion: 2009
First posted: Apr 9, 2009
Registry last updated: Apr 9, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed